Neurophage Discovers GAIM-Changing Molecules to Combat Alzheimer's Disease and Other Neurodegenerative Disorders
Tuesday, April 22, 2014 - 08:20
in Biology & Nature
Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.